ONCOARENDI THERAPEUTICS SP Z O O has a total of 16 patent applications. Its first patent ever was published in 2014. It filed its patents most often in China, United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets organic fine chemistry, pharmaceuticals and measurement are ANAMAR AB, INFINITY PHARMACEUTICALS INC and PHARMAGENE LAB LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | United States | 4 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | Australia | 1 | |
#5 | Canada | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | India | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals | |
#3 | Measurement | |
#4 | Basic materials chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Cholody Wieslaw Marek | 8 |
#2 | Pikul Stanislaw Wieslaw | 8 |
#3 | Olejniczak Sylwia | 6 |
#4 | Koralewski Robert | 6 |
#5 | Golebiowski Adam A | 5 |
#6 | Olczak Jacek | 5 |
#7 | Czestkowski Wojciech J | 4 |
#8 | Matyszewski Krzysztof | 4 |
#9 | Olczak Jacek P | 3 |
#10 | Beckett Paul R | 2 |
Publication | Filing date | Title |
---|---|---|
WO2016108707A1 | Arginase inhibitors and their therapeutic applications | |
US2016176843A1 | Substituted amino triazoles useful as acidic mammalian chitinase inhibitors | |
AU2014252281A1 | Derivatives of 1-(substituted sulfonyl)-2-aminoimidazoline as antitumor and antiproliferative agents |